- Home
- TRU vs HOLX Comparison
TRU vs HOLX Comparison
Compare TRU & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRU
- HOLX
- Stock Information
- Founded
- TRU 1968
- HOLX 1985
- Country
- TRU United States
- HOLX United States
- Employees
- TRU N/A
- HOLX N/A
- Industry
- TRU Finance: Consumer Services
- HOLX Medical Electronics
- Sector
- TRU Finance
- HOLX Health Care
- Exchange
- TRU Nasdaq
- HOLX Nasdaq
- Market Cap
- TRU 18.0B
- HOLX 16.3B
- IPO Year
- TRU 2015
- HOLX 1990
- Fundamental
- Price
- TRU $91.70
- HOLX $64.50
- Analyst Decision
- TRU Buy
- HOLX Buy
- Analyst Count
- TRU 13
- HOLX 14
- Target Price
- TRU $113.50
- HOLX $85.42
- AVG Volume (30 Days)
- TRU 1.6M
- HOLX 2.3M
- Earning Date
- TRU 02-13-2025
- HOLX 02-05-2025
- Dividend Yield
- TRU 0.50%
- HOLX N/A
- EPS Growth
- TRU N/A
- HOLX 50.83
- EPS
- TRU 1.45
- HOLX 3.16
- Revenue
- TRU $4,183,800,000.00
- HOLX $4,039,000,000.00
- Revenue This Year
- TRU $8.16
- HOLX $5.33
- Revenue Next Year
- TRU $9.86
- HOLX $5.72
- P/E Ratio
- TRU $63.47
- HOLX $20.47
- Revenue Growth
- TRU 9.20
- HOLX 1.76
- 52 Week Low
- TRU $66.07
- HOLX $62.70
- 52 Week High
- TRU $113.17
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- TRU 40.34
- HOLX 34.25
- Support Level
- TRU $90.83
- HOLX $62.70
- Resistance Level
- TRU $96.58
- HOLX $65.18
- Average True Range (ATR)
- TRU 2.86
- HOLX 1.55
- MACD
- TRU -0.39
- HOLX -0.18
- Stochastic Oscillator
- TRU 8.40
- HOLX 17.36
About TRU TransUnion
TransUnion is one of the three leading credit bureaus in the United States, providing the consumer information that is the basis for granting credit. The company also provides fraud detection, marketing, and analytical services. TransUnion operates in over 30 countries, and about a quarter of its revenue comes from international markets.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.